Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cell Pathways completes phase Ib trial of CP-461

Aug. 7, 2000

Pfizer discontinues phase III trials of prinomastat in advanced cancers

Aug. 7, 2000

Cyclin-dependent kinase inhibitors under study at Roche

Aug. 4, 2000

Foscan PDT shows promise as treatment for head and neck cancer

Aug. 4, 2000

Allos Therapeutics completes patient enrollment for RSR-13 trial in lung cancer

Aug. 4, 2000

European Commission approves Myocet as treatment of metastatic breast cancer

Aug. 4, 2000

Bavarian Nordic initiates phase I/II trial of metastatic malignant melanoma treatment

Aug. 3, 2000

NIH offers apoptosis-inducing gene product for licensing

Aug. 3, 2000

CuraGen researchers identify SECX polypeptides useful for diagnosis, treatment of cancer

Aug. 2, 2000

Apoptosis-inducing retinamides described by Roche

Aug. 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....